F 0554
Allow residents to self-administer drugs if determined clinically appropriate.
Level of Harm - Minimal harm
or potential for actual harm
Based on observations, interviews, record review, and facility policy review, the facility failed to ensure a
resident was assessed to determine if self-administration of medication was clinically appropriate for 1
(Resident #48) of 6 sampled residents reviewed for medication administration. Specifically, Resident #48
was found with two white pills in a small cup at bedside with no staff present without an assessment of the
resident's ability to safely self-administer the medication.
Residents Affected - Few
Findings included:
A review of a facility policy titled, Medications, Self-Administration, reviewed on 01/31/2022, revealed, It is
the policy of this facility that an individual resident may self-administer specific medications if the IDT
[interdisciplinary team] has determined that this practice is safe, and physician orders are obtained for
self-administration of the specific medication(s). The policy specified, 2. If a resident voices desire to
self-administer medications, the IDT is to assess the resident's cognitive, physical and visual ability to carry
out this responsibility. 3. A licensed nurse is to complete the Self-Administration of Medication Assessment
(UDA) [user defined assessment]. The resident is to be asked to read and understand the directions on the
pharmacy label, and to administer his/her medications in the presence of a licensed nurse to demonstrate
the ability to take the medication according to the safe practice and facility policy. 4. The self-administration
assessment and any other information is to be reviewed by the resident's physician and IDT for final
determination of the resident's ability to self-administer medications. The policy indicated, The resident may
not begin self-administration of medications prior to the approval of the physician and IDT.
A review of Resident #48's admission Record revealed the facility admitted the resident on 09/29/2023 with
diagnoses that included end stage renal disease and dependence on renal dialysis.
A review of an admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of
10/04/2023, revealed Resident #48 had a Brief Interview for Mental Status (BIMS) score of 15, indicating
the resident was cognitively intact. Per the MDS, Resident #48 received dialysis while residing in the facility.
A review of Resident #48's care plan revised on 10/01/2023, t indicated the resident needed hemodialysis
related to renal failure.
A review of Resident #48's Order Summary Report, that listed active orders as of 10/30/2023, revealed an
order dated 09/29/2023, for sevelamer carbonate (a medication used to lower high blood phosphorus levels
in patients on dialysis) 800 milligrams (mg), two tablets by mouth before meals for hypocalcemia. There was
no physician's order for Resident #48 to self-administer their medications.
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 11
Event ID:
555901
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0554
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
A review of Resident #48's Scheduling Details dated 09/29/2023, for the sevelamer carbonate 800 mg
indicated the medication should be administered by a clinician. The options for Supervised
Self-Administration and Unsupervised Self-Administration were not selected.
In a concurrent observation and interview on 10/30/2023 at 11:37 AM, the surveyor noted two white pills in
a small cup on Resident #48's bedside table while no staff was present in the resident's room. Resident #48
stated the two white pills in the small cup were phosphorus binders they took when they ate their meals.
Resident #48 said they did not eat breakfast that morning, so they asked the nurse to leave the pills, and
the resident planned to take one pill halfway through the next meal and the other after eating. Resident #48
further stated the facility staff had not spoken with the resident about self-administering the phosphate
binder, but the nurses stood there while the resident took the rest of their medications.
During an interview on 10/31/2023 at 1:26 PM, Licensed Vocational Nurse (LVN) #2 stated Resident #48
took the sevelamer carbonate when they ate and requested the nursing staff to leave the pills at bedside,
so they had them available when they chose to eat. LVN #2 further stated Resident #48 had no swallowing
difficulties and took this medication on their own at home. LVN #2 said Resident #48 sometimes did not eat
their breakfast, so they did not take their sevelamer carbonate. LVN #2 said when this happened, the
resident did not always let nursing staff know.
During an interview on 11/02/2023 at 2:41 PM, the Director of Nursing (DON) stated if a resident wanted to
self-administer medications, the facility must first assess the resident to determine if they were able, then
the staff would obtain a physician's order. The DON said this process was important to ensure the resident
could safely self-administer the medication. The DON said a self-administration assessment for Resident
#48 to self-administer their sevelamer carbonate was not conducted until 10/31/2023.
During an interview on 11/02/2023 at 2:51 PM, the Administrator stated he expected the nursing staff to
follow the facility's procedure for medication self-administration. The Administrator said an assessment must
be completed, it must be care planned, and there should be a physician's order in place for residents to
self-administer medications. Per the Administrator, Resident #48's medication self-administration
assessment was completed after they found out the resident took their medications on their own. The
Administrator further stated it was important to follow the facility's medication self-administration procedure
for resident safety.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 2 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
PASARR screening for Mental disorders or Intellectual Disabilities
Level of Harm - Minimal harm
or potential for actual harm
Based on interviews, record review, facility document review, and facility policy review, the facility failed to
ensure a Level II evaluation was completed after a positive Level I Preadmission Screening and Resident
Review (PASARR) for 1 (Resident #65) of 1 sampled resident reviewed for PASARRs.
Residents Affected - Few
Findings included:
Review of guidance from the California Department of Health Care Services (DHCS), dated 08/09/2023,
indicated, Purpose: The PASRR [Preadmission Screening and Resident Review] Information Notice (IN)
clarifies the Hospitals' and SNFs' [skilled nursing facilities'] responsibilities to provide MCPs [Medi-Cal
Managed Care Plans, health care for people with low or no income] confirmation that a PASRR Level I
Screening was completed and to provide completed PASRR documentation for cases that advance to a
Level II Evaluation with SNF referrals for prior authorization. Further review of the guidance indicated,
PASRR documentation is no longer required to be sent to the MCP when a Level I Screening is negative for
SMI [serious mental illness] and/or ID/DD/RC [intellectual disability/developmental disability/related
condition]. It is only required when a Level I Screening is positive for SMI and/or ID/DD/RC and the case
advances to a Level II Evaluation. Under this scenario, the MCP's approval of the prior authorization
request will be pending until PASRR documentation is received. Once the PASRR process is completed,
Hospitals and SNFs must provide the resulting Level II Evaluation letter to the MCP within three calendar
days of issuance to obtain approval of the prior authorization request for SNF placement.
A review of Resident #65's admission Record indicated the facility admitted the resident on 10/10/2023 with
diagnoses that included bipolar disorder.
Review of an admission Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of
10/16/2023, revealed Resident #65 had a Brief Interview for Mental Status (BIMS) score of 15, which
indicated the resident was cognitively intact.
Review of Resident #65's care plan with an initiation date of 10/13/2023, revealed the resident had a
mental health history that included bipolar disorder.
A review of a letter from DHCS dated 10/10/2023 and sent to Resident #65 related to their positive Level I
(PASARR) screening, indicated the facility would be contacted within two to four days to set up an
appointment for an evaluator to conduct a Level II mental health evaluation. The letter also indicated that
once the Level II mental health evaluation was completed, the resident would receive a report that provided
recommendations for specialized services. The letter indicated a copy of the letter was also sent to the
facility.
A review of Resident #65's medical record, revealed no evidence of a Level II mental health evaluation.
During an interview on 10/31/2023 at 11:28 AM, the Administrator said the facility received Resident #65's
positive Level I PASARR when the facility admitted the resident, but the facility failed to note that the
resident needed a Level II evaluation within two to four days of their positive Level I. The Administrator
stated that it was the MDS Coordinator's responsibility to review a positive Level I PASARR upon admission
and the MDS Coordinator should have noted the request to have a Level II evaluation.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 3 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 11/02/2023 at 10:31 AM, MDS Coordinator #6 stated that when the facility received
a positive Level I PASARR, it was the MDS Coordinator's responsibility to ensure that a Level II evaluation
was conducted in a timely manner. She said she was not working when the facility admitted Resident #65,
so MDS Coordinator #7 would have reviewed the resident's Level I PASARR. She stated the positive Level I
PASARR should have been caught and addressed when Resident #65 was first admitted so the resident
subsequently received all the mental health services the resident needed for their mental illness.
During an interview on 11/02/2023 at 10:41 AM, MDS Coordinator #7 stated that when the facility received
Resident #65's positive Level I PASARR, she should have reached out to the transferring facility for
information regarding the resident's mental illness and psychoactive medications so a Level II evaluation
could be scheduled. MDS Coordinator #7 stated the importance of getting the Level II evaluation was to
ensure the resident received necessary care and services for their mental illness. She said that she did not
know why the Level II evaluation was missed for Resident #65.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 4 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Provide appropriate treatment and care according to orders, resident’s preferences and goals.
Level of Harm - Minimal harm
or potential for actual harm
Based on interviews, record review, and policy review, the facility failed to ensure staff monitored the skin
as ordered by the physician for 1 (Resident #36) of 2 sampled residents reviewed for skin issues.
Residents Affected - Few
Findings included:
Review of a facility policy titled, Skin Assessments, dated 07/18/2023, revealed Purpose: To ensure that
every resident admitted to and residing at the facility has their skin checked on a routine basis for any
conditions that require medical intervention. If skin breakdown occurs, a resident is to receive the
appropriate treatment per physician's order.
Review of Resident #36's admission Record revealed the facility readmitted the resident on 10/06/2023 with
diagnoses that included fracture of neck of the left femur (hip area) and age-related osteoporosis with a
current pathological fracture.
Review of Resident #36's admission Minimum Date Set (MDS), with an Assessment Reference Date (ARD)
dated 10/12/2023, revealed the resident had a Brief Interview for Mental Status (BIMS) of 11, which
indicated the resident had moderate cognitive impairment. The MDS revealed the resident surgical
wound(s) and received surgical wound care.
Review of Resident #36's care plan dated 10/10/2023, revealed the resident had skin impairment as
evidenced by a surgical site. The facility developed interventions that directed staff to monitor the skin each
shift and report any changes to the physician and to provide treatment per the physician's order.
Review of Resident #36's Order Summary Report which included active order as of 10/31/2023, revealed
an ordered dated 10/06/2023, to monitor surgical site to the left hip each shift for signs and symptoms of
infection and notify medical doctor. The resident also had a physician's order dated 10/07/2023, to monitor
the surgical site to the resident's back each shift for signs and symptoms of infection and notify the medical
doctor.
Review of Resident #36's Treatment Administration Record [TAR] for October 2023, revealed staff
documented the surgical site to the resident's back and left hip were monitored three times daily from
10/07/2023 to 10/31/2023. The TAR revealed, Licensed Vocational Nurse (LVN) #5 documented she
monitored each of the resident's surgical sites on the evening shift on 10/29/2023 and 10/30/2023. Per the
TAR, LVN #3 documented she monitored each of the resident's surgical sites each day shift from
10/25/2023 to 10/28/2023.
Review of Resident #36's Skin Assessment dated 10/22/2023, revealed the surgical incision to the
resident's lower back was scabbed and healing well. A review of the Skin Assessment, dated 10/25/2023,
revealed the wound care physician examined the resident and noted there were no signs/symptoms of
infection to the resident's left hip surgical site.
During an interview on 10/30/2023 at 1:56 PM, Resident #36 stated they had surgical incisions. The
resident stated the site to their left hip had not healed and no one at the facility had looked at their surgical
sites.
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 5 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0684
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
During an interview on 11/01/2023 at 12:08 PM, LVN #3 stated she had not looked at Resident #36's
surgical site to their back or hip. LVN #3 stated Resident #36 was at the facility after a fracture, and the
facility staff were to monitor the resident for signs and symptoms of an infection. LVN #3 stated she did not
know where the resident's surgical sites were located and had not visualized the surgical sites. LVN #3
stated she had signed off on the TAR, indicating she completed monitoring of the resident's surgical sites,
even though she had not seen or monitored the surgical sites. LVN #3 stated not following orders could lead
to infection and complications.
During an interview on 11/01/2023 at 1:53 PM, LVN #5 stated Resident #36 had a surgical site to their back
only and she was not aware of any other surgical sites to the resident had. LVN #5 stated she should not
have documented that monitoring of both surgical sites was completed.
During an interview on 11/01/2023 at 2:38 PM, the Medical Doctor (MD) stated when there was an order to
monitor incision sites each shift, he expected the nursing staff to monitor and look for signs of warmth,
cellulitis, redness, and pain of the site. The MD also stated he expected the nurses to visually inspect the
sites.
In an interview on 11/02/2023 at 2:56 PM, the Director of Nursing (DON) stated the nursing staff should
have completed daily skin monitoring of the surgical sites for Resident #36. Per the DON, the nursing staff
should not document completion on the TAR if they had not completed the skin monitoring.
During an interview on 11/02/2023 at 3:26 PM, the Administrator stated staff should not document
completion of a skin assessment if the staff had not completed the assessment.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 6 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
Provide safe and appropriate respiratory care for a resident when needed.
Level of Harm - Minimal harm
or potential for actual harm
Based on observations, interviews, record review, and policy reviews, the facility failed to ensure a bi-level
positive airway pressure (BiPAP) mask and an updraft nebulizer mask were stored in a bag when they were
not in use for 1 (Resident #58) of 2 sampled residents reviewed for respiratory care.
Residents Affected - Few
Findings included:
Review of a facility policy titled, CPAP [continuous positive airway pressure] and BiPAP Use, revised on
01/31/2022, revealed, 11. Nursing staff is to ensure that the CPAP/BiPAP is kept clean at all times, and that
the mask is cleaned according to the manufacturer's recommendations prior to each use.
Review of a facility policy titled, Nebulizer Treatments, revised on 01/31/2022, revealed, 4. Remove
nebulizer from plastic bag. Connect tubing to oxygen source and fill the nebulizer with prescribed
medication. a. Nebulizer tubing and storage bags are to be changed weekly, on Sundays, and dated when
changed.
A review of Resident #58's admission Record indicated the facility readmitted the resident on 09/27/2023
with diagnoses that included acute and chronic respiratory failure with hypoxia, obstructive sleep apnea
(OSA), chronic obstructive pulmonary disease (COPD), and dependence on supplemental oxygen.
A review of Resident #58's admission Minimum Data Set (MDS), with an Assessment Reference Date
(ARD) of 10/02/2023, revealed Resident #58 had a Brief Interview of Mental Status (BIMS) score of 15,
indicating the resident was cognitively intact. The MDS revealed the resident received oxygen therapy and a
non-invasive mechanical ventilator.
Review of Resident #58's care plan with an initiation date of 10/04/2023, indicated the resident had
shortness of breath (SOB) related to emphysema/COPD, OSA, and chronic respiratory failure.
Review of Resident #58's Order Summary Report indicated an order dated 10/01/2023, for BiPAP 14/5 with
oxygen (O2) every 12 hours as needed. The Order Summary Report revealed an order dated 10/23/2023,
for albuterol sulfate inhalation nebulization solution every four hours as needed for SOB or wheezing and
ipratropium-albuterol solution every six hours as needed for SOB or wheezing for 30 days.
In an observation on 10/30/2023 at 10:38 AM, Resident #58's BiPAP mask and updraft nebulizer mask
were noted lying on top of the resident's bed side table. The masks were not in bags or covered.
Resident #58 said the nurses put their BiPAP mask on and took it off. The resident said the last time the
BiPap mask was used was on 10/29/2023. Resident #58 also stated they received an updraft nebulizer
treatment earlier this morning (10/30/2023).
In an observation on 10/31/2023 at 7:23 AM, the surveyor noted Resident #58's BiPAP and updraft
nebulizer mask were lying on top of the resident's bed side table and were not covered or in bags.
During an observation on 11/01/2023 at 7:56 AM, the surveyor noted Resident #58's BiPAP mask was lying
on top of the bed side table uncovered and not in a bag. Resident #58 said they did not wear the
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 7 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0695
BiPAP last night and it had been on top of the bed side table since the morning before.
Level of Harm - Minimal harm
or potential for actual harm
During an interview on 11/01/2023 at 7:58 AM, Licensed Vocational Nurse (LVN) #3 said BiPAP and updraft
nebulizer masks were to be kept in bags in residents' rooms when they were not in use.
Residents Affected - Few
During a telephone interview on 11/01/2023 at 2:39 PM, LVN #8 stated the normal process after
administering a resident's updraft nebulizer treatment or when the staff took off a resident's BiPAP mask
was to put the masks away; specifically, put them in bags. She indicated she gave Resident #58's updraft
nebulizer treatment at 6:00 AM on 10/30/2023 and on 10/31/2023. She also indicated she did not know why
she did not put the mask in a bag after she administered the resident their updraft nebulizer treatment but
should have. LVN #8 said she had removed Resident #58's BiPAP mask several times lately and should
have placed it in a bag when it was not in use.
During an interview on 11/02/2023 at 7:05 AM, LVN #9 said BiPAP masks and updraft nebulizer masks
were supposed to be stored in bags when they were not in use. She confirmed that she took off Resident
#58's BiPAP mask Monday morning (10/30/2023) and had also given the resident their 6:00 AM updraft
nebulizer treatment. She indicated she should have placed them in bags to prevent the spread of infection.
During an interview on 11/02/2023 at 2:48 PM, the Director of Nursing indicated she expected BiPAP and
updraft nebulizer masks to be placed in bags when they were not in use to prevent the spread of infection
and prevent the risk of a respiratory infection.
During an interview on 11/02/2023 at 3:19 PM, the Administrator stated that his expectation was to have
the resident's BiPAP mask and updraft nebulizer mask placed in bags or covered when they were not in use
to prevent the spread of infection.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 8 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Implement gradual dose reductions(GDR) and non-pharmacological interventions, unless contraindicated,
prior to initiating or instead of continuing psychotropic medication; and PRN orders for psychotropic
medications are only used when the medication is necessary and PRN use is limited.
Based on interviews, record review, and policy review, the facility failed to ensure a resident's medication
regimen was free from unnecessary medications for 1 (Resident #17) of 5 sampled residents reviewed for
unnecessary medications. Specifically, Resident #17 had an order for lorazepam 0.5 milligrams (mg), one
tablet by mouth every six hours as needed (PRN) for anxiety and agitation started on 06/15/2023 with no
specified duration (stop date).
Findings included:
A review of a facility policy titled, Medications, Psychotherapeutic Drugs, reviewed on 01/31/2022, revealed,
Purpose: To provide a therapeutic environment using only those medications with a therapeutic value to
individual residents. The use of unnecessary drugs is to be avoided whenever possible. Policy: It is the
policy of this facility that psychotherapeutic drugs will not be administered for purposes of discipline or
convenience, and if required is to be used to treat the resident's medical symptoms. Each resident's drug
regimen is to be free from unnecessary drugs. The section of the policy titled, Psychotherapeutic Drug
Management specified, 3. Physician's orders for the psychotherapeutic medications must specify a f. Stop
Date or Duration.
A review of Resident #17's admission Record revealed the facility admitted the resident on 05/17/2022 with
diagnoses that included type 2 diabetes mellitus and chronic kidney disease. Per the admission Record, on
06/14/2023, the resident received a diagnosis of anxiety disorder.
A review of a quarterly Minimum Data Set (MDS), with an Assessment Reference Date (ARD) of
09/14/2023, revealed Resident #17 had a Brief Interview for Mental Status (BIMS) score of 13, indicating
the resident was cognitively intact. Per the MDS, Resident #17 received hospice services while a resident
of the facility and did not receive antianxiety medication during the seven-day assessment period.
A review of Resident #17's care plan initiated on 06/20/2023, indicated the resident received antianxiety
medication for an anxiety diagnosis manifested by agitation.
A review of Resident #17's Order Summary Report, which listed active orders as of 11/02/2023, revealed
an order dated 06/15/2023, for lorazepam 0.5 mg, one tablet by mouth every six hours PRN for anxiety and
agitation. The order did not specify the duration of use (stop date).
A review of a Note to Attending Physician/Prescriber, signed by a consultant pharmacist and dated
09/30/2023, revealed the following information regarding the pharmacist's review of Resident #17's PRN
lorazepam order, patient is currently on PRN Lorazepam (Ativan) with the following diagnosis: anxiety.
Please evaluate current diagnosis, behaviors and usage patterns and evaluate continued need. PRN
psychotropic orders cannot exceed 14 days with the exception that the prescriber documents their rationale
in the resident's medical record and indicate the duration for the PRN order. The handwritten
physician/prescribed response indicated the medication was started when the resident was placed in
hospice care on 06/14/2023 and there would be no changes in the medication at this time.
During an interview on 11/01/2023 at 2:37 PM, the Medical Director stated he did not like using PRN
antianxiety medications but received quite a bit of negative push back from the nurses and family
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 9 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0758
members who wanted the PRN medications available, so he just left the orders in place.
Level of Harm - Minimal harm
or potential for actual harm
During an interview on 11/01/2023 at 3:56 PM, the Pharmacist stated PRN antianxiety medications should
have a stop date included in the order and the use should be re-evaluated after 14 days. The Pharmacist
further stated she notified facilities and physicians that there was no exception on PRN antianxiety use for
hospice residents and that the orders still needed to have a stop date.
Residents Affected - Few
During an interview on 11/02/2023 at 2:41 PM, the Director of Nursing stated the facility tried to keep PRN
antianxiety medications active for only 14 days but if the physician felt it appropriate for a hospice resident,
they kept the PRN order in place.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 10 of 11
Printed: 05/15/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
555901
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
11/02/2023
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
Anberry Transitional Care
1000 West Yosemite Avenue
Merced, CA 95341
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Many
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
Based on observations, interviews, and policy review, the facility failed to ensure drugs and biologicals were
stored in locked compartments and not left unlocked while they were unattended by authorized staff. This
deficient practice was observed for 2 of 2 treatment carts in the facility and had the potential to affect all
residents who resided on the 200 and 300 halls.
Findings included:
Review of a facility policy titled, Medications Storage, with a review date of 01/31/2022, revealed, It is the
policy of this facility that all medications, drugs and biologicals are to be stored in a safe, secure and orderly
manner, at a temperature as directed by the manufacturer, and accessible to only licensed nurses and the
pharmacist in accordance with federal and state regulations.
During an observation on 10/31/2023 at 7:21 AM, the treatment cart on the 300 Hall was observed
unlocked and unattended. The contents of the treatment cart included tubes of lidocaine ointment (an
aesthetic used to prevent and treat pain from some procedures, minor burns, scrapes, and insect bites),
clotrimazole betamethasone cream (a combination medication used to treat a variety of inflamed fungal
skin infections), permethrin cream (a medication used to treat scabies), and triamcinolone cream (a
medication used to treat a variety of skin conditions).
During an observation of the 200 Hall on 11/01/2023 at 12:06 PM, the surveyor noted the key was in left in
the lock of the treatment cart and the treatment cart was unlocked and unattended. Licensed Vocational
Nurse (LVN) #3 stated she accidentally left the key in the treatment cart lock and forgot to lock the cart.
During an observation on 11/02/2023 at 1:08 PM, the treatment cart on the 200 Hall was unlocked and
unattended. The contents of the treatment cart included antifungal cream and antifungal powder.
In an interview on 11/02/2023 at 1:13 PM, LVN #3 stated the last person who accessed the 200 Hall
treatment cart was LVN #12.
During an interview on 11/02/2023 at 2:01 PM, LVN #12 confirmed she left the treatment cart unlocked and
unattended and stated she thought she locked the cart.
During an interview on 11/02/2023 3:56 PM, the Administrator stated it was his expectation that medication
and treatment carts be locked when not in the line of sight of staff, and the keys be removed from the carts.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
555901
If continuation sheet
Page 11 of 11